People · Operator
Named in public records as an officer, director or promoter · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CardioVascular BioTherapeutics, Inc. | — | Biotechnology | Series C | $49.0M | $203.8M | — |
Calvin A Wallen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Calvin A Wallen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mickael A Flaa | 1 | 2 |
| Grant A Gordon | 1 | 1 |
| James R Richards | 1 | 1 |
| Jon A Ross | 1 | 1 |
| Robert A Schleizer | 1 | 1 |
| Al R Moran | 1 | 1 |
| Robert Wayne Blackburn | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.